VICC Associate Director, Strategic Relations and Research Partnerships
Co-Director/Co-Leader, GI Oncology Research Program
Exec Direc, YA Cancers Program
💠NCT06608927
💠Gem/Nab-paclitaxel +/- Quemlicustat (Q)
💠Based on promising Ib activity
💠Q is a CD73 inhibitor to enhance antitumor immunity
#DrDanaCardinMD @pancan.bsky.social #cancerresearch
💠NCT06608927
💠Gem/Nab-paclitaxel +/- Quemlicustat (Q)
💠Based on promising Ib activity
💠Q is a CD73 inhibitor to enhance antitumor immunity
#DrDanaCardinMD @pancan.bsky.social #cancerresearch
🙏🏻 to the great team at #VanderbiltUnivMedCenter!
Polyps removed so back again in 3 yrs👍
👉It takes 5-10 yrs for a polyp to become cancerous
👉A colonoscopy removes all precancerous polyps.
👉Get screened!!!
#colorectalcancer #cancerprevention
@fightcrc.bsky.social
🙏🏻 to the great team at #VanderbiltUnivMedCenter!
Polyps removed so back again in 3 yrs👍
👉It takes 5-10 yrs for a polyp to become cancerous
👉A colonoscopy removes all precancerous polyps.
👉Get screened!!!
#colorectalcancer #cancerprevention
@fightcrc.bsky.social
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
✅ 2.5 mg PO BID Apixaban = 5.0 mg po BID x 12M for primary endpoint of recurrent thrombosis. #cancer #cancerresearch #NEJM
✅ 2.5 mg PO BID Apixaban = 5.0 mg po BID x 12M for primary endpoint of recurrent thrombosis. #cancer #cancerresearch #NEJM
☑️OS 23.7M vs. 20.6M vs lenvatinib or sorafenib (HR, 0.79; 95% CI, 0.65-0.96; P = .018).
@FDAOncology @EAHPBA #immunotherapy @bristolmyerssquibb.bsky.social #cancer #CancerResearch #Checkmate9DW
☑️OS 23.7M vs. 20.6M vs lenvatinib or sorafenib (HR, 0.79; 95% CI, 0.65-0.96; P = .018).
@FDAOncology @EAHPBA #immunotherapy @bristolmyerssquibb.bsky.social #cancer #CancerResearch #Checkmate9DW
☑️Median PFS was NR in the combo arm vs. 39.3M (HR = 0.62 [95% CI: 0.48, 0.81]
☑️ORR = 71% vs. 58% (p-value 0.0011)
#CancerResearch #immunotherapy @bristolmyerssquibb.bsky.social
☑️Median PFS was NR in the combo arm vs. 39.3M (HR = 0.62 [95% CI: 0.48, 0.81]
☑️ORR = 71% vs. 58% (p-value 0.0011)
#CancerResearch #immunotherapy @bristolmyerssquibb.bsky.social
Great Debates in Solid Tumors.
@greatdebates.bsky.social
Register: hmpglobalevents.com/gdst/agenda
🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch
Great Debates in Solid Tumors.
@greatdebates.bsky.social
Register: hmpglobalevents.com/gdst/agenda
🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch
For ALL young adults 20-50 y/o with #cancer.
Newsletter Link: shorturl.at/t7p7F
#patientcare #tooyoung #AYA #unmetneeds
@vumc-insights.bsky.social #CancerResearch
For ALL young adults 20-50 y/o with #cancer.
Newsletter Link: shorturl.at/t7p7F
#patientcare #tooyoung #AYA #unmetneeds
@vumc-insights.bsky.social #CancerResearch
🔵 R U >/= 45 yo?
🔵Have U had a change in bowel habits?
🔵Do U have a family hx of #ColorectalCancer or uterine #cancer ?
🔵 Any unresolved symptoms?
👉🏻 Talk to your MD
#ColorectalCancerAwarenessMonth @vumc-insights.bsky.social
🔵 R U >/= 45 yo?
🔵Have U had a change in bowel habits?
🔵Do U have a family hx of #ColorectalCancer or uterine #cancer ?
🔵 Any unresolved symptoms?
👉🏻 Talk to your MD
#ColorectalCancerAwarenessMonth @vumc-insights.bsky.social
#earlyonset #colorectal #cancer PMID: 39674189
💠#EOCRC incidence rising in 27 of 50 countries
💠For past 10 yrs, the greatest AAPC: #NZ (3·97%), #Chile (3·96%), #PR (3·81%), and #England (3·59%). #cancerprevention #CancerAwareness @vumc-insights.bsky.social
#earlyonset #colorectal #cancer PMID: 39674189
💠#EOCRC incidence rising in 27 of 50 countries
💠For past 10 yrs, the greatest AAPC: #NZ (3·97%), #Chile (3·96%), #PR (3·81%), and #England (3·59%). #cancerprevention #CancerAwareness @vumc-insights.bsky.social